# Innovate Edmonton

> Innovate Edmonton is a VC fund in Edmonton backing Medical and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Edmonton, Canada
- Total investments: 1
- Last investment: Jan 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/innovateedmonton/
- Website: https://x.com/InnovateYEG
- Facebook: https://www.facebook.com/InnovateYEG

Innovate Edmonton is a VC fund in Edmonton focused on Medical and Health Care. Innovate Edmonton, a division of Edmonton Economic Development Corporation (EEDC), supports our city’s most driven tech-sector entrepreneurs and visionaries. The division’s purpose is to help founders and their teams bring ground-breaking ideas to market – whether as a startup or a high-potential scaleup – by bringing together the right people,resources and funding.

## Contacts

5 contacts available for Innovate Edmonton. Shizune tracks 1 team members at Innovate Edmonton. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/innovate-edmonton?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Catherine Warren | Chief Executive Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Syantra | Syantra is a precision biotechnology company that transforms cancer detection and treatment. The company is initially targeting breast cancer detection and treatment, highlighting its commitment to combatting this prevalent disease. Syantra''s flagship product, Syantra DX™ Breast Cancer, is a blood test designed for early breast cancerscreening. This test measures a panel of gene expression biomarkers from whole blood and utilizes machine learning algorithms to interpret the data, providing a positive or negative result. Clinical studies have demonstrated high inferred accuracy for women under 50 and overall. Syantra's Onco-ID™ platform aims to expand early cancer detection capabilities across multiple cancer types. | $6.8M | Series A | Jan 20, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Accelerate Fund](https://shizune.co/investors/profile/accelerate-fund) — VC Fund, 1 deal together
- [Alberta Innovates](https://shizune.co/investors/profile/alberta-innovates-e699) — VC Fund, 1 deal together
- [Plug and Play](https://shizune.co/investors/profile/plug-and-play-ventures) — VC Fund, 1 deal together
- [The Opportunity Calgary Investment Fund](https://shizune.co/investors/profile/the-opportunity-calgary-investment-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Innovate Edmonton invest in?

Innovate Edmonton invests primarily in Medical, Health Care and Therapeutics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Innovate Edmonton?

Public channels for Innovate Edmonton include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Innovate Edmonton?

The team at Innovate Edmonton includes Catherine Warren (Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
